It’s Worth $60,000 per Gallon… And You Won’t Believe Where It Comes From

Written by Jason Simpkins
Posted September 13, 2018 at 8:00PM

It’s used to test every drug certified by the FDA.

And for that reason it’s being called “the medical equivalent of gold.”

What is it?

Well, it’s blood.

And it comes from horseshoe crabs.

Isn’t that something?

Here we are in the 21st century and scientists are saying all of modern medicine would be sent back to the dark ages if it weren’t for the blood of this strange prehistoric creature.

You see, the horseshoe crab’s blood cells are so sensitive to bacteria that they can actually detect the presence of ANY bacterial contamination. Even at a concentration of one part per trillion they’ll zero in on it like a homing missile.

blue_blood_190x190The Medical Equivalent of Gold

This rare fluid is worth $60,000 a gallon: 
Without its strange powers, Big Pharma would completely go out of business. 
One small company has quietly cornered the market on this substance, soaking up 90% of the world's supply.
You could ride it for 10,000% gains.
Find out how.

The National Institutes of Health says there's nothing else like it, artificial or naturally occurring. No other compound can test the purity of medicines and sterility of equipment with this level of accuracy.

That makes it indispensable, and exceedingly expensive.

As I said, it’s valued at $60,000 per gallon. And there’s such a huge demand for it, that there are huge, sprawling laboratories dedicated to producing it.

See that?

It looks like an assembly line.

But here’s the thing: There are only FOUR in the world.

No doubt, if extracting this substance were cheap, or easy, everyone would do it.

But it’s not.

It’s an incredibly sophisticated process.

And that’s why one company dominates this critical market.

That company works for every one of the 100 largest global drug developers, literally sucking the blood out of crustaceans so we don’t get sick — or so that if we do get sick there’s a well-tested cure at our hands.

It’s there so that whenever a patient needs a syringe, a scalpel, a bone replacement, or any of more than 1,450 FDA-approved drugs, they can get one that’s been thoroughly sanitized.

Make no mistake, there are millions of lives at stake, here.

And billions of dollars.

The medical device market is expected to grow to $173 billion over the next year. And the prescription drug market is projected to grow to $610 billion in that time.

Again, that’s why this strange, but vital, liquid is worth an astonishing $60,000 per gallon.

And it’s why this is such a unique and amazing investment opportunity.

Jimmy Mengel, who has spent the past year racking up huge gains on marijuana stocks with his extremely popular Marijuana Manifesto, has plucked this company from obscurity and made it the latest recommendation in his Crow’s Nest portfolio.

According to his detailed report, which you can find here, this one stock is going to deliver investors quadruple-digit gains.

Like I said, it’s a fascinating story (and profit opportunity) that you’re not going to hear about anywhere else.

Fight on,

Jason Simpkins Signature

Jason Simpkins

follow basic@OCSimpkins on Twitter

Jason Simpkins is Assistant Managing Editor of the Outsider Club and Investment Director of The Wealth Warrior, a financial advisory focused on security companies and defense contractors. For more on Jason, check out his editor's page. 

*Follow Outsider Club on Facebook and Twitter.


Investing in Marijuana Without Getting Burned